07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

DIP<br />

83262<br />

DTAB<br />

83269<br />

FDIPY<br />

90371<br />

Coagulation recommends performing additional confirmatory tests prior to diagnosing or repeating<br />

DRVVT when patient is off anti-vitamin K therapy.<br />

<strong>Test</strong> Performed <strong>By</strong>: Esoterix Coagulation<br />

8490 Upland Dr.<br />

Suite 100<br />

Englewood, CO 80112<br />

Diphtheria Toxoid IgG Antibody Assay, Serum<br />

Clinical Information: In the United States, diphtheria toxoid is administered to children as part of the<br />

combined diphtheria-pertussis-tetanus vaccine. Anti-diphtheria toxoid antibodies form in response to<br />

vaccination using diphtheria toxoid protein. This immunoassay, which uses the same protein (toxoid) that<br />

is used in the vaccine, provides a measurement of specific IgG antibodies produced in response to<br />

vaccination.<br />

Useful For: Determining a patient's immunological response to diphtheria toxoid vaccination As an aid<br />

in the evaluation of immunodeficiency<br />

Interpretation: Results greater than or equal to 0.10 IU/mL suggest a vaccine response.<br />

Reference Values:<br />

The minimum level of protective antibody in the normal population is between 0.01 and 0.1 IU/mL. The<br />

majority of vaccinated individuals should demonstrate protective levels of antibody >0.1 IU/mL.<br />

Clinical References: 1. Booy R, Aitken SJ, Taylor S, et al: Immunogenicity of combined diphtheria,<br />

tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet<br />

1992;339(8792):507-510 2. Maple PA, Efstratiou A, George RC, et al: Diphtheria immunity in UK blood<br />

donors. Lancet 1995;345(8955):963-965 3. WHO meeting report: The Control of Diphtheria in Europe.<br />

WHO ref:EUR/ICP/EPI/024 1990<br />

Diphtheria/Tetanus Antibody Panel, Serum<br />

Clinical Information: See Individual Unit Codes<br />

Useful For: See Individual Unit Codes<br />

Interpretation: See Individual Unit Codes<br />

Reference Values:<br />

DIPHTHERIA TOXOID IgG ANTIBODY ASSAY<br />

The minimum level of protective antibody in the normal population is between 0.01 and 0.1 IU/mL. The<br />

majority of vaccinated individuals should demonstrate protective levels of antibody >0.1 IU/mL.<br />

TETANUS TOXOID IgG ANTIBODY ASSAY<br />

The minimum level of protective antibody in the normal population is between 0.01 and 0.15 IU/mL.<br />

The majority of vaccinated individuals should demonstrate protective levels of antibody >0.15 IU/mL.<br />

Clinical References: See Individual Unit Codes<br />

Dipyridamole<br />

Reference Values:<br />

Reporting limit determined each analysis<br />

Synonym(s): Persantine<br />

Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong><strong>Laboratories</strong>.com Page 618

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!